Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ceska Gynekol ; 79(2): 128-33, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24874827

ABSTRACT

OBJECTIVE: To assess the adverse effects of the chronic use of zidovudine/lopinavir/ritonavir in a rat pregnancy model.Type of article: Original paper. DESIGN: A prospective experimental study. SETTING: Department of Obstetrics, São Paulo Federal University (UNIFESP). METHODS: 40 pregnant EPM-1 albino rats were randomly allocated into four groups of 10 animals each: control (Ctrl) group (untreated) and three experimental groups (Exp1, Exp2 and Exp3), which received zidovudine/lopinavir/ritonavir in the corresponding doses of 10/13.3/3.3; 30/39.9/9.9 and 90/119.7/29.7 mg/Kg/day from the first up to the 20th day of pregnancy, respectively. The rats were treated by gavage daily. Body weights were recorded on days 0, 7, 14 and 20. At term, the rats were sacrificed and the implantation sites, number of live and dead fetuses and placentas, resorptions and fetal and placental weights were recorded. The fetuses were evaluated for external abnormalities under a stereomicroscope. The chi-square test was used to compare death rates between groups. RESULTS: Weight gain during pregnancy no showed significant differences between groups. Average weight gains between the 7th and 20th day were 45.70 ± 5.27 g for Ctrl; 48.49 ± 3.64 g for Exp1; 45.39 ± 6.22 g for Exp2 and 44.19 ± 6.78 g for Exp3. However, the percentage weight gain in the 7th was lower in groups Exp2 and Exp3 and in the 14th in the Group Exp2. All other parameters assessed did not differ significantly between groups. Exp2 and Exp3 in relation of the others. CONCLUSIONS: The chronic exposure of pregnant rats to high doses of zidovudine/lopinavir/ritonavir in association resulted in a significant reduction in maternal body weight gain but was not associated with significant adverse fetal parameters.


Subject(s)
Antiretroviral Therapy, Highly Active/methods , HIV Infections/drug therapy , Pregnancy Complications, Infectious , Pregnancy, Animal , Animals , Disease Models, Animal , Female , Pregnancy , Prospective Studies , Rats , Rats, Wistar
2.
J Dairy Sci ; 89(7): 2705-15, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16772589

ABSTRACT

The effects of increasing levels of solvent-extracted palm kernel meal (SPKM) and corn distillers dried grains (CDG) in corn silage-based diets on feed intake and milk production were examined in 2 experiments. In Experiment 1, 20 Holstein cows averaging 100 d in milk (DIM) (SD = 61.5) at the start of the experiment were utilized in an 11-wk randomized complete block design with 4 treatments in 5 blocks to study effects of increasing levels of SPKM in the diet. During a 3-wk preliminary period, cows were fed a standard diet. At the end of the preliminary period, cows were blocked by 4% fat-corrected milk yield, parity number (primiparous and multiparous), and DIM, and were assigned randomly to 1 of 4 experimental diets. The total mixed ration (TMR) consisted of (dry matter basis) 40% corn silage, 5% coarsely chopped wheat straw, and 55% concentrate. The increasing dietary levels of SPKM were achieved by replacing protein sources and citrus pulp with SPKM and urea (0, 5, 10, and 15% SPKM and 0.06, 0.22, 0.38, and 0.55% urea for SPKM0, SPKM5, SPKM10, and SPKM15, respectively). In Experiment 2, 18 Holstein cows averaging 93 DIM (SD = 49.1) at the start of the experiment were utilized in an 11-wk randomized complete block design with 3 treatments in 6 blocks to study effects of increasing levels of CDG in the diet. The preliminary period lasted for 2 wk. Assignment of cows to treatments was the same as in Experiment 1. The TMR consisted of (dry matter basis) 40% corn silage, 5% coarsely chopped wheat straw, and 55% concentrate. The increasing dietary levels of CDG were achieved by replacing soybean meal and citrus pulp with CDG and urea (0, 7, and 14% CDG and 0, 0.22, and 0.49% urea for CDG0, CDG7, and CDG14, respectively). There were no significant treatment effects on dry matter intake, milk yield, or milk composition in Experiment 1. Inclusion of SPKM tended to increase protein and lactose contents of milk. The SPKM0 diet promoted body weight loss. There were no treatment effects in Experiment 2, except for milk protein content, which was decreased by CDG. Plasma Lys concentration tended to be affected by SPKM and CDG inclusions. Plasma concentrations of 3-methylhistidine and Leu seemed to be related to body protein degradation/synthesis. The feeding of SPKM up to 15% in the diet decreased feed costs without detrimental effects on productive responses and tended to increase milk protein content. The inclusion of CDG in diets based on corn silage and corn byproducts might decrease milk protein content due to an unbalanced supply of AA, particularly Lys.


Subject(s)
Arecaceae/chemistry , Cattle/physiology , Diet , Seeds/chemistry , Silage , Zea mays , Amino Acids/blood , Animal Feed/analysis , Animal Feed/economics , Animals , Body Weight , Dietary Proteins/administration & dosage , Eating , Female , Lactation , Milk/chemistry , Milk Proteins/analysis , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Silage/analysis , Zea mays/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...